Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 58

1.

HIIT Improves Left Ventricular Exercise Response in Adults with Type 2 Diabetes.

Wilson GA, Wilkins GT, Cotter JD, Lamberts RR, Lal S, Baldi JC.

Med Sci Sports Exerc. 2019 Jun;51(6):1099-1105. doi: 10.1249/MSS.0000000000001897.

PMID:
30640284
2.

Cough-Induced Takotsubo (Stress) Cardiomyopathy.

Lal S, Pemberton J, Wilkins GT.

CASE (Phila). 2018 May 18;2(6):240-242. doi: 10.1016/j.case.2018.03.004. eCollection 2018 Dec. No abstract available.

3.

Breeding Characteristics and Dose-dependent Blood Pressure Responses of Transgenic Cyp1a1-Ren2 Rats.

Leader CJ, Clark BJ, Hannah AR, Sammut IA, Wilkins GT, Walker RJ.

Comp Med. 2018 Oct 1;68(5):360-366. doi: 10.30802/AALAS-CM-17-18000026. Epub 2018 Sep 5.

4.

Endovascular Renal Denervation in End-Stage Kidney Disease Patients: Cardiovascular Protection-A Proof-of-Concept Study.

Hoye NA, Wilson LC, Wilkins GT, Jardine DL, Putt TL, Samaranayaka A, Schollum JBW, Walker RJ.

Kidney Int Rep. 2017 May 4;2(5):856-865. doi: 10.1016/j.ekir.2017.04.012. eCollection 2017 Sep.

5.

Impaired ventricular filling limits cardiac reserve during submaximal exercise in people with type 2 diabetes.

Wilson GA, Wilkins GT, Cotter JD, Lamberts RR, Lal S, Baldi JC.

Cardiovasc Diabetol. 2017 Dec 19;16(1):160. doi: 10.1186/s12933-017-0644-1.

6.

Safety and performance of the second generation EnligHTN™ Renal Denervation System in patients with drug-resistant, uncontrolled hypertension.

Worthley SG, Wilkins GT, Webster MW, Montarello JK, Delacroix S, Whitbourn RJ, Warren RJ.

Atherosclerosis. 2017 Jul;262:94-100. doi: 10.1016/j.atherosclerosis.2017.04.022. Epub 2017 May 3.

7.

Resting heart rate variability and exercise capacity in Type 1 diabetes.

Wilson LC, Peebles KC, Hoye NA, Manning P, Sheat C, Williams MJA, Wilkins GT, Wilson GA, Baldi JC.

Physiol Rep. 2017 Apr;5(8). pii: e13248. doi: 10.14814/phy2.13248.

8.

β-Adrenergic Responsiveness in the Type 2 Diabetic Heart: Effects on Cardiac Reserve.

Wilson GA, Wilson LC, Lamberts RR, Majeed K, Lal S, Wilkins GT, Baldi JC.

Med Sci Sports Exerc. 2017 May;49(5):907-914. doi: 10.1249/MSS.0000000000001184.

PMID:
27984428
9.

The Type 2 Diabetic Heart: Its Role in Exercise Intolerance and the Challenge to Find Effective Exercise Interventions.

Baldi JC, Wilson GA, Wilson LC, Wilkins GT, Lamberts RR.

Sports Med. 2016 Nov;46(11):1605-1617. doi: 10.1007/s40279-016-0542-9. Review.

PMID:
27106558
10.

Complications of intra-aortic balloon pump use: does the final position of the IABP tip matter?

Siriwardena M, Pilbrow A, Frampton C, MacDonald SM, Wilkins GT, Richards AM.

Anaesth Intensive Care. 2015 Jan;43(1):66-73.

11.

Prevalence of abdominal aortic aneurysm in patients referred for transthoracic echocardiography.

Majeed K, Hamer AW, White SC, Pegg TJ, Wilkins GT, Williams SM, Chen YH, Williams MJ.

Intern Med J. 2015 Jan;45(1):32-9. doi: 10.1111/imj.12592.

PMID:
25266859
12.

A Y-shaped bifurcation-dedicated stent for the treatment of de novo coronary bifurcation lesions: an IVUS analysis from the BRANCH trial.

Sakata K, Koo BK, Waseda K, Nakatani D, Yock PG, Whitbourn R, Worthley SG, Ormiston J, Webster M, Wilkins GT, Honda Y, Meredith IT, Fitzgerald PJ.

EuroIntervention. 2015 Mar 22;10(11):e1-8. doi: 10.4244/EIJY14M08_16.

13.

Endovascular renal denervation: a novel sympatholytic with relevance to chronic kidney disease.

Hoye NA, Baldi JC, Putt TL, Schollum JB, Wilkins GT, Walker RJ.

Clin Kidney J. 2014 Feb;7(1):3-10. doi: 10.1093/ckj/sft130. Epub 2013 Nov 8.

14.

Poisonous plants in New Zealand: a review of those that are most commonly enquired about to the National Poisons Centre.

Slaughter RJ, Beasley DM, Lambie BS, Wilkins GT, Schep LJ.

N Z Med J. 2012 Dec 14;125(1367):87-118. Review.

PMID:
23321887
15.

Intra-individual changes of active matrix metalloproteinase-9 are associated with clinical in-stent restenosis of bare metal stents.

Tarr GP, Williams MJ, Wilkins GT, Chen VH, Phillips LV, van Rij AM, Jones GT.

Cardiology. 2013;124(1):28-35. doi: 10.1159/000345591. Epub 2013 Jan 3.

PMID:
23295453
16.

Influence of the glutathione peroxidase 1 Pro200Leu polymorphism on the response of glutathione peroxidase activity to selenium supplementation: a randomized controlled trial.

Miller JC, Thomson CD, Williams SM, van Havre N, Wilkins GT, Morison IM, Ludgate JL, Skeaff CM.

Am J Clin Nutr. 2012 Oct;96(4):923-31. Epub 2012 Sep 5.

PMID:
22952184
17.

Plasma active matrix metalloproteinase 9 and indices of diastolic function in patients with preserved systolic function.

Chu JW, Jones GT, Tarr GP, Phillips LV, Wilkins GT, van Rij AM, Williams MJ.

Int J Cardiol. 2013 Aug 20;167(4):1242-6. doi: 10.1016/j.ijcard.2012.03.147. Epub 2012 Apr 10.

PMID:
22494867
18.

Rapid cycle change to predominantly radial access coronary angiography and percutaneous coronary intervention: effect on vascular access site complications.

Nadarasa K, Robertson MC, Wong CK, Green BK, Chen VH, Wilkins GT, Williams MJ.

Catheter Cardiovasc Interv. 2012 Mar 1;79(4):589-94. doi: 10.1002/ccd.23120. Epub 2011 Jun 6.

PMID:
21523899
19.

Plasma active matrix metalloproteinase 9 associated to diastolic dysfunction in patients with coronary artery disease.

Chu JW, Jones GT, Tarr GP, Phillips LV, Wilkins GT, van Rij AM, Williams MJ.

Int J Cardiol. 2011 Mar 3;147(2):336-8. doi: 10.1016/j.ijcard.2010.12.093. Epub 2011 Jan 28. No abstract available.

PMID:
21276625
20.

Long-term clinical outcomes with the next-generation Resolute Stent System: a report of the two-year follow-up from the RESOLUTE clinical trial.

Meredith IT, Worthley SG, Whitbourn R, Walters D, McClean D, Ormiston J, Horrigan M, Wilkins GT, Hendriks R, Matsis P, Muller D, Cutlip DE.

EuroIntervention. 2010 Jan;5(6):692-7.

PMID:
20142220
21.

Active matrix metalloproteinases 3 and 9 are independently associated with coronary artery in-stent restenosis.

Jones GT, Tarr GP, Phillips LV, Wilkins GT, van Rij AM, Williams MJ.

Atherosclerosis. 2009 Dec;207(2):603-7. doi: 10.1016/j.atherosclerosis.2009.05.036. Epub 2009 Jun 17.

PMID:
19576586
22.

Elevated plasma active matrix metalloproteinase-9 level is associated with coronary artery in-stent restenosis.

Jones GT, Kay IP, Chu JW, Wilkins GT, Phillips LV, McCormick M, van Rij AM, Williams MJ.

Arterioscler Thromb Vasc Biol. 2006 Jul;26(7):e121-5. Epub 2006 May 11.

PMID:
16690873
23.

Clinical outcome of older patients with acute coronary syndrome over the last three decades.

Tang EW, Wong CK, Restieaux NJ, Herbison P, Williams MJ, Kay P, Wilkins GT.

Age Ageing. 2006 May;35(3):280-5.

PMID:
16638768
24.

Expanding retrograde saphenous vein graft aneurysm treated with endovascular coiling.

Parry DJ, Winburn IC, Wilkins GT, Bunton RW.

Ann Thorac Surg. 2005 Dec;80(6):2374-6.

PMID:
16305919
25.

Accuracy of monitoring for sleep-related breathing disorders in the coronary care unit.

Skinner MA, Choudhury MS, Homan SD, Cowan JO, Wilkins GT, Taylor DR.

Chest. 2005 Jan;127(1):66-71.

PMID:
15653964
26.

Actinomycin-eluting stent for coronary revascularization: a randomized feasibility and safety study: the ACTION trial.

Serruys PW, Ormiston JA, Sianos G, Sousa JE, Grube E, den Heijer P, de Feyter P, Buszman P, Schömig A, Marco J, Polonski L, Thuesen L, Zeiher AM, Bett JH, Suttorp MJ, Glogar HD, Pitney M, Wilkins GT, Whitbourn R, Veldhof S, Miquel K, Johnson R, Coleman L, Virmani R; ACTION investigators.

J Am Coll Cardiol. 2004 Oct 6;44(7):1363-7.

28.

Spontaneous Coronary Artery Dissection Presenting as Unstable Angina.

Kay IP, Wilkins GT, Williams MJ.

J Invasive Cardiol. 1998 Jun;10(5):274-276. No abstract available.

PMID:
10762800
29.

Assessment of the mechanical properties of coronary arteries using intravascular ultrasound: an in vivo study.

Williams MJ, Stewart RA, Low CJ, Wilkins GT.

Int J Card Imaging. 1999 Aug;15(4):287-94.

PMID:
10517378
30.

Impaired endothelial function following a meal rich in used cooking fat.

Williams MJ, Sutherland WH, McCormick MP, de Jong SA, Walker RJ, Wilkins GT.

J Am Coll Cardiol. 1999 Mar 15;33(4):1050-5.

31.

Long stenting in native coronary arteries: relation between vessel size and outcome.

Kerr AJ, Stewart RA, Low CJ, Restieaux NJ, Wilkins GT.

Cathet Cardiovasc Diagn. 1998 Jun;44(2):170-4.

PMID:
9637439
32.

Differences in easily recognised coronary risk factors by age at first myocardial infarction.

Stewart RA, Robertson MC, Low CJ, Wilkins GT, Restieaux NJ.

N Z Med J. 1997 Sep 12;110(1051):339-40. No abstract available.

PMID:
9323375
33.

Valvular heart disease: putting guidelines into practice.

Wilkins GT.

BMJ. 1997 May 17;314(7092):1428-9. No abstract available.

34.

Primary stenting as treatment for coronary-subclavian steal syndrome.

Kerr AJ, Williams MJ, Wilkins GT.

Aust N Z J Med. 1997 Feb;27(1):80-1. No abstract available.

PMID:
9079262
35.

Association between activity at onset of symptoms and outcome of acute myocardial infarction.

Stewart RA, Robertson MC, Wilkins GT, Low CJ, Restieaux NJ.

J Am Coll Cardiol. 1997 Feb;29(2):250-3.

36.

Plasma natriuretic peptides and cardiac volume during acute changes in intravascular volume in haemodialysis patients.

Corboy JC, Walker RJ, Simmonds MB, Wilkins GT, Richards AM, Espiner EA.

Clin Sci (Lond). 1994 Dec;87(6):679-84.

PMID:
7874859
37.

Long-term effects of acute thrombolytic therapy on ventricular size and function.

Picard MH, Wilkins GT, Ray P, Weyman AE.

Am Heart J. 1993 Jul;126(1):1-10.

PMID:
8322649
38.

Interaction between corticosteroid and beta-agonist drugs. Biochemical and cardiovascular effects in normal subjects.

Taylor DR, Wilkins GT, Herbison GP, Flannery EM.

Chest. 1992 Aug;102(2):519-24.

PMID:
1353717
39.

Progressive changes in ventricular structure and function during the year after acute myocardial infarction.

Picard MH, Wilkins GT, Ray PA, Weyman AE.

Am Heart J. 1992 Jul;124(1):24-31.

PMID:
1535474
40.

Unusual sequelae after percutaneous mitral valvuloplasty: a Doppler echocardiographic study.

O'Shea JP, Abascal VM, Wilkins GT, Marshall JE, Brandi S, Acquatella H, Block PC, Palacios IF, Weyman AE.

J Am Coll Cardiol. 1992 Jan;19(1):186-91.

41.
43.

Prediction of successful outcome in 130 patients undergoing percutaneous balloon mitral valvotomy.

Abascal VM, Wilkins GT, O'Shea JP, Choong CY, Palacios IF, Thomas JD, Rosas E, Newell JB, Block PC, Weyman AE.

Circulation. 1990 Aug;82(2):448-56.

PMID:
2372892
44.

Follow-up of patients undergoing percutaneous mitral balloon valvotomy. Analysis of factors determining restenosis.

Palacios IF, Block PC, Wilkins GT, Weyman AE.

Circulation. 1989 Mar;79(3):573-9.

PMID:
2917388
45.
46.

Inaccuracy of mitral pressure half-time immediately after percutaneous mitral valvotomy. Dependence on transmitral gradient and left atrial and ventricular compliance.

Thomas JD, Wilkins GT, Choong CY, Abascal VM, Palacios IF, Block PC, Weyman AE.

Circulation. 1988 Oct;78(4):980-93.

PMID:
3168200
47.

Echocardiographic evaluation of mitral valve structure and function in patients followed for at least 6 months after percutaneous balloon mitral valvuloplasty.

Abascal VM, Wilkins GT, Choong CY, Thomas JD, Palacios IF, Block PC, Weyman AE.

J Am Coll Cardiol. 1988 Sep;12(3):606-15.

48.

Responsiveness of plasma atrial natriuretic factor to short-term changes in left atrial hemodynamics after percutaneous balloon mitral valvuloplasty.

Waldman HM, Palacios IF, Block PC, Wilkins GT, Homcy CJ, Graham RM, Fifer MA.

J Am Coll Cardiol. 1988 Sep;12(3):649-55.

49.

Percutaneous balloon mitral valvotomy for patients with mitral stenosis. Analysis of factors influencing early results.

Herrmann HC, Wilkins GT, Abascal VM, Weyman AE, Block PC, Palacios IF.

J Thorac Cardiovasc Surg. 1988 Jul;96(1):33-8.

PMID:
3386292
50.

Correlation between echocardiographic endocardial surface mapping of abnormal wall motion and pathologic infarct size in autopsied hearts.

Wilkins GT, Southern JF, Choong CY, Thomas JD, Fallon JT, Guyer DE, Weyman AE.

Circulation. 1988 May;77(5):978-87.

PMID:
3359595

Supplemental Content

Loading ...
Support Center